![]() (another brother of John Gregory - Joseph Gregory - was then the president of Monarch Pharmaceuticals) acquired ownership of the U.S. The King Pharmaceuticals wholly owned subsidiary Monarch Pharmaceuticals, Inc. revenues for HMR and Hoechst had stopped promoting Altace within the United States., and King Pharmaceuticals President Jefferson "Jeff" Gregory also began negotiations in 1995 with Hoechst to acquire U.S. Altace was bringing in under $90 million in U.S. pharmaceutical subsidiary Hoechst Marion Roussel (HMR). Hoechst merged with Marion Merrill Dow of Kansas City, Missouri in 1995, forming the Hoechst U.S. marketing and distribution rights to Altace The King Pharmaceuticals subsidiary Monarch Pharmaceuticals acquired one of its most profitable branded drugs, Altace, later the same year on Decemfrom Hoechst Marion Roussel. King Pharmaceuticals obtained about twenty smaller branded drugs from the start up of the company until it went public in June 1998. By December 1998 King had placed its sterile products business into a subsidiary it named Parkedale Pharmaceuticals. In February 1998, King acquired 15 branded pharmaceuticals, a sterile products manufacturing facility located in Rochester, Michigan that it called the "Parkedale Facility") and some contract manufacturing contracts. King initially manufactured drugs for other pharmaceutical companies, but soon established a strategy of acquiring branded prescription drugs, which have a much higher gross margin than contract manufactured drugs. The 500,000-square-foot (46,000 m 2) facility was purchased for $1.18 million from RSR Pharmaceutical, who had been using it after Beecham merged with SmithKline. In January 1994, King acquired a former King College campus plant in Bristol, Tennessee. King Pharmaceuticals was founded in 1993 John M. ![]() and Monarch Pharmaceuticals Ireland Limited. King Pharmaceuticals Research and Development, Inc. Securities and Exchange Commission, the wholly owned subsidiaries of King Pharmaceuticals, Inc. Form 10-K for the year ended Decemfiled with the U.S. According to the King Pharmaceutcals, Inc. was incorporated in the State of Tennessee in 1993. They employed approximately 2,700 people including a sales force of over 1,000 individuals. Petersburg, Florida and Middleton, Wisconsin. King Pharmaceuticals operated manufacturing facilities in Bristol, Tennessee Rochester, Michigan St. King produced a wide range of pharmaceuticals, including Altace for heart attack prevention, Levoxyl for hypothyroidism, Sonata, a sleeping aid, and Skelaxin, a muscle relaxant. On October 12, 2010, King was acquired by Pfizer for $14.25 per share. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company. Gift of William H.King Pharmaceuticals, is a pharmaceutical company, a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. ![]() ![]() Overall: 3 1/2 in x 5 1/2 in 8.89 cm x 13.97 cm ID Number United States: Michigan, Rochester Physical Description United States: New York, West Nyack place depicted Postcard, pharmaceutical company date made Photo caption on back of postcard reads: "Parkedale Laboratories / Parke-Davis / Rochester, Michigan / New buildings have been added to our facilities at Parkedale, Rochester, Michigan, to centralize development of Biologicals and to provide isolation of areas for Polio and Adenovirus vaccines." Printed by Dexter Press, Inc., West Nyack, New York, number 72334-B. Color postcard showing an aerial photograph of the Parke Davis Company's Parkedale Laboratories in Rochester, Michigan. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |